Hoth Therapeutics, Inc.
NASDAQ: HOTH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robb Knie
- Employees
- 6
- Headquarters
- New York, United States
- IPO year
- 2019
- Market cap
- $12.9M
- Website
- https://www.hoththerapeutics.com
Loading HOTH…
Loading profile data…Frequently asked questions about HOTH
What does Hoth Therapeutics, Inc. (HOTH) do?
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatme...
Where does HOTH trade?
Hoth Therapeutics, Inc. (HOTH) trades on the NASDAQ.
What sector is HOTH in?
Hoth Therapeutics, Inc. (HOTH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hoth Therapeutics, Inc.?
Robb Knie is the chief executive officer of Hoth Therapeutics, Inc. (HOTH).
Where is Hoth Therapeutics, Inc. headquartered?
Hoth Therapeutics, Inc. is headquartered in United States.
Does HOTH pay a dividend?
Hoth Therapeutics, Inc. (HOTH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HOTH go public?
Hoth Therapeutics, Inc. (HOTH) completed its initial public offering in 2019.